SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: BigKNY3 who wrote (4862)8/12/1998 1:53:00 AM
From: BigKNY3  Respond to of 9523
 

Stks 'Near Bottom' Of Tumble; Fundamentals Good - Analysts

NEW YORK (Dow Jones)--The stock market downturn is nearing its bottom and will begin to rebound as investors focus on the strong fundamentals driving the market, two market insiders agreed.

Mary Farrell, an equity strategist at PaineWebber Inc., said the latest market losses are nothing more than a "very normal correction."

Low interest rates and the potential for stronger corporate earnings in coming quarters will woo investors back to the fold, she told CNBC.

Gerold Klauer, co-chairman of Gerard Klauer Mattison & Co., said small- and mid-cap stocks look particularly promising as the market's decline begins to shallow out.

Included in Klauer's stock picks are several companies in the consumer sector, including Gap Inc. (GPS), Abercrombie & Fitch Co. (ANF) and The Limited Inc. (LTD).

"Consumers are still upbeat" about their own financial situations, he said.

Farrell also likes smaller-cap issues, especially technology stocks, which she said suffered a particularly severe selloff over the last few weeks.

However, drug stocks topped her list of embattled stocks to be had on the cheap. She named Warner-Lambert Co. (WLA) and Schering-Plough Corp. (SGP) as two bargains in the sector